Act for Ultra Rare's latest lobbying report covers Q2 2026, at $37.5K. Its first report covers Q1 2026; the issues it reports most are Health Issues.

Act for Ultra Rare

Latest quarter: $37.5K; Q2 2026 · 1 reports
Last 12 months: $75K; Last 2 quarters
vs last quarter: 0.0%; Q2 2026 against the quarter before
First report: Q1 2026; The first quarter a report named it

Lobbying by quarter

Policy issues the reports name

Health issues2 reports

A report that names several issues counts once for each.

Who was lobbied

HOUSE OF REPRESENTATIVES2 reports

Firms it paid

Firm
Aviva Strategies	$75K	2 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

	Filed by		Issues
07/17for Q2	Aviva Strategies	$37.5K	Health issues
04/20for Q1	Aviva Strategies	$37.5K	Health issues
04/17for Q1	Aviva Strategies	Under $5,000	Health issues